Humira can be very expensive, and the price depends on country, insurance, dose, and whether you’re using the brand or a biosimilar. Here’s a general sense for the US:
- List price (per 40 mg injection, pen or syringe): roughly $5,000–$7,000.
- Typical dosing for many conditions is 40 mg every other week after loading doses, which usually means about 2 injections per month.
- If you were paying the list price without insurance, that could translate to about $10,000–$14,000 per month, or roughly $120,000–$168,000 per year—though most people don’t pay full list price.
Your out-of-pocket depends a lot on:
- Insurance plan (deductibles, copays, coinsurance)
- Pharmacy and dispensing fees
- Eligibility for manufacturer savings programs or patient assistance
- Availability of biosimilars, which can be cheaper
What you can do to get a clearer figure:
- Ask your pharmacy for the cash price of Humira 40 mg (pen or syringe).
- Check with your insurer about your specific copay/coinsurance and whether a Humira biosimilar is preferred on your plan.
- Look into patient savings programs: AbbVie’s Humira savings program and other manufacturer coupons (note that some programs have restrictions on government insurance plans).
- If cost is a barrier, ask your clinician about biosimilars or alternative regimens that may be covered.
If you tell me:
- Your country,
- Whether you have private insurance, government insurance, or no insurance,
- The exact dosing schedule you’ll be using (e.g., loading doses and then every other week),
I can tailor a more precise estimate and point you to price-check resources.